Plain-English translation of NCT06318273 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This trial is testing , an experimental medication given through an IV, to treat men with advanced prostate cancer that has spread and no longer responds to standard hormone treatments. The study will first test different doses of the medication to find the safest and most effective amount, and then confirm those findings in a larger group of patients. Researchers want to understand how well this treatment works and what side effects it may cause.
Advanced prostate cancer that stops responding to hormone therapy is difficult to treat, and many men need better options. This trial is exploring whether this new medication could help control the cancer and improve outcomes for patients who have run out of other treatment choices.
You would visit a hospital or clinic regularly over up to 3 years to receive the medication as an intravenous infusion every 3 weeks. You'll have frequent blood tests, imaging scans (CT or MRI), and medical check-ups to monitor how you're responding to treatment and watch for side effects. The study has two main phases: first, finding the right dose for you, and then confirming that dose works well in a larger group of patients like you.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States